Related Experiment Video
Updated: May 27, 2026

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Nitrates and other nitric oxide donors in cardiology: current positioning and perspectives
Francesco Iachini Bellisarii1, Francesco Radico, Francesca Muscente
1Institute of Cardiology, "G. d'Annunzio" University - Chieti, Chieti, Italy.
Insights
Nitric oxide donors are vital for cardiovascular disease therapy but face inconsistent use due to tolerance and endothelial dysfunction concerns. Further research is needed to clarify their optimal application and long-term efficacy.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Nitric oxide (NO) donors have a long history in treating cardiovascular diseases.
- Despite widespread use, cardiologists lack consistent guidelines on their indications and administration.
- Contradictory pharmacodynamics, including acute efficacy versus long-term tolerance and endothelial dysfunction, create therapeutic challenges.
Purpose of the Study:
- To review recent biochemical and pathophysiological findings on nitric oxide donors.
- To re-evaluate the role of nitrates and other NO donors in cardiovascular medicine.
- To compare international guidelines and identify areas needing further clinical research.
Main Methods:
- Literature review of biochemical and pathophysiological studies.
- Analysis of pharmacodynamic properties of NO donors.
- Comparative review of international clinical guidelines.
Main Results:
- Acute administration of NO donors is effective.
- Long-term use may be limited by tolerance and endothelial dysfunction.
- Inconsistent clinical application highlights a need for clearer guidance.
Conclusions:
- The long-term efficacy and safety of nitric oxide donors require further investigation.
- Clarifying indications and optimal administration is crucial for consistent clinical practice.
- More clinical research is warranted to address current uncertainties regarding NO donor therapy.
Abstract:
Nitric oxide donors have been commonly used in the therapy of cardiovascular disease for more than 150 years. In spite of this longevity and the popularity of their use, it appears somewhat paradoxical that there is no current consistent use among cardiologists, as to both their indications and their optimal mode of administration. In part this results from their contradictory pharmacodynamics: when given acutely, their effectiveness is undisputable; however, their long-term efficacy is potentially limited by the development of tolerance and the induction of endothelial dysfunction, which may have negative prognostic implications. This review reports recent biochemical and pathophysiological acquisitions, re-examines the role of nitrates and other nitric oxide donors in cardiovascular medicine, comparing and commenting on international guidelines; and highlights areas of uncertainty, where more clinical research with these drugs would still be warranted.
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Angina V: Nursing Management
Angina IV: Management
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

